Medication info
SimbaDuet Tablet 10/10mg

SimbaDuet Tablet 10/10mg

Prescription medicationTabletOral
Ingredient · strength
Ezetimibe›10mg / 1 tabletSimvastatin›10mg / 1 tablet
Manufacturer / importer
Daewoo Pharmaceutical Co., Ltd.
Appearance
White to light yellow, bilaterally convex, rectangular tablet
Packaging
30 tablets per box [30 tablets (10 tablets/PTPX3)]
Approval status
Active

MFDS item code 201907684 · Approved 2019.11.04

Summary

Main use
Improvement of hypercholesterolemia (primary and homozygous familial) and mixed hyperlipidemia
Who takes it
Adults
Adult dose
Patients should follow a standard cholesterol-lowering diet before and during treatment with this medicine. The dose of this medicine should be adjusted according to the patient's baseline LDL cholesterol level, recommended treatment goal, and response. This medicine is administered once daily in the evening, regardless of meals. Patients with primary hypercholesterolemia The dose range of this medicine is 10/10mg~10/40mg daily. The generally recommended initial dose is 10/20mg daily. Patients who require less LDL cholesterol reduction may start at 10/10mg daily. After starting this medicine or adjusting the dose, check blood lipid levels at intervals of at least 4 weeks and then adjust the dose. Because of the increased risk of myopathy, including rhabdomyolysis, particularly during the first year of treatment, the 10/80 mg dose of this medicine should be used only in patients who have been taking this medicine 10/80 mg for 12 months or longer without evidence of muscle toxicity (see section 1. Warnings in Precautions for Use). Patients with homozygous familial hypercholesterolemia The recommended dose for patients with homozygous familial hypercholesterolemia is 10/40mg daily, administered once daily in the evening. This medicine is administered as an adjunct to other lipid-lowering treatments (e.g., LDL apheresis) or when other lipid-lowering treatments are not useful. Administration to patients with hepatic impairment Dose adjustment is not necessary in patients with mild hepatic impairment, but use of this medicine is not recommended in patients with moderate or severe hepatic impairment (see section 5. General Precautions, Patients with Abnormal Liver Function). Administration to patients with renal impairment and patients with chronic kidney disease Dose adjustment is not necessary in patients with mild renal impairment (estimated glomerular filtration rate (GFR) ≥ 60mL/min/1.73㎡). For patients with chronic kidney disease and an estimated glomerular filtration rate < 60mL/min/1.73㎡, administer this medicine 10/20mg once daily in the evening. If higher doses of this medicine are administered to these patients, use with caution and monitor closely (see section 5. General Precautions). Administration to elderly patients Dose adjustment is not necessary in elderly patients. Concomitant administration with other medicines (See section 6. Interactions in Precautions for Use.) Administer this medicine at least 2 hours before or at least 4 hours after a bile acid sequestrant. Patients receiving this medicine concomitantly with verapamil, diltiazem, or dronedarone should not exceed 10/10mg/day of this medicine. Patients receiving this medicine concomitantly with amiodarone, amlodipine, or ranolazine should not exceed 10/20mg/day of this medicine.

Ingredients

Manufacturer
Daewoo Pharmaceutical Co., Ltd.

Efficacy & effects

Improvement of hypercholesterolemia (primary and homozygous familial) and mixed hyperlipidemia

  • Primary hypercholesterolemia
  • heterozygous familial hypercholesterolemia
  • non-familial hypercholesterolemia
  • mixed hyperlipidemia
  • homozygous familial hypercholesterolemia
  • atherosclerotic vascular disease caused by hypercholesterolemia
View approved original text

This medication is used in conjunction with a diet to lower total cholesterol, LDL cholesterol, Apo B protein, and triglyceride levels in patients with primary hypercholesterolemia and mixed hyperlipidemia, while increasing HDL cholesterol. It is particularly used as an adjunct in patients with homozygous familial hypercholesterolemia when other lipid-lowering therapies are insufficient. This medication is used with consideration of risk factors in patients at high risk of atherosclerotic vascular disease due to hypercholesterolemia, and dietary and lifestyle modifications are necessary. Prior to administration, potential secondary causes such as diabetes or hypothyroidism should be identified and treated. During treatment, regular monitoring of cholesterol and triglyceride levels is conducted. This medication is indicated for the effective treatment of hypercholesterolemia.

How to take

Adult dose

Patients should follow a standard cholesterol-lowering diet before and during treatment with this medicine. The dose of this medicine should be adjusted according to the patient's baseline LDL cholesterol level, recommended treatment goal, and response. This medicine is administered once daily in the evening, regardless of meals. Patients with primary hypercholesterolemia The dose range of this medicine is 10/10mg~10/40mg daily. The generally recommended initial dose is 10/20mg daily. Patients who require less LDL cholesterol reduction may start at 10/10mg daily. After starting this medicine or adjusting the dose, check blood lipid levels at intervals of at least 4 weeks and then adjust the dose. Because of the increased risk of myopathy, including rhabdomyolysis, particularly during the first year of treatment, the 10/80 mg dose of this medicine should be used only in patients who have been taking this medicine 10/80 mg for 12 months or longer without evidence of muscle toxicity (see section 1. Warnings in Precautions for Use). Patients with homozygous familial hypercholesterolemia The recommended dose for patients with homozygous familial hypercholesterolemia is 10/40mg daily, administered once daily in the evening. This medicine is administered as an adjunct to other lipid-lowering treatments (e.g., LDL apheresis) or when other lipid-lowering treatments are not useful. Administration to patients with hepatic impairment Dose adjustment is not necessary in patients with mild hepatic impairment, but use of this medicine is not recommended in patients with moderate or severe hepatic impairment (see section 5. General Precautions, Patients with Abnormal Liver Function). Administration to patients with renal impairment and patients with chronic kidney disease Dose adjustment is not necessary in patients with mild renal impairment (estimated glomerular filtration rate (GFR) ≥ 60mL/min/1.73㎡). For patients with chronic kidney disease and an estimated glomerular filtration rate < 60mL/min/1.73㎡, administer this medicine 10/20mg once daily in the evening. If higher doses of this medicine are administered to these patients, use with caution and monitor closely (see section 5. General Precautions). Administration to elderly patients Dose adjustment is not necessary in elderly patients. Concomitant administration with other medicines (See section 6. Interactions in Precautions for Use.) Administer this medicine at least 2 hours before or at least 4 hours after a bile acid sequestrant. Patients receiving this medicine concomitantly with verapamil, diltiazem, or dronedarone should not exceed 10/10mg/day of this medicine. Patients receiving this medicine concomitantly with amiodarone, amlodipine, or ranolazine should not exceed 10/20mg/day of this medicine.

Precautions

This medication can cause serious muscle-related side effects such as myopathy and rhabdomyolysis, so patients must notify their doctor immediately if they experience muscle pain, weakness, or tenderness. This medication should not be administered to patients with poor liver function or active liver disease, and liver function tests should be conducted regularly. Women who are pregnant or breastfeeding should not take this medication, and women planning to become pregnant should consult with a doctor before use. This medication may interact with certain drugs, increasing the risk of muscle side effects, so if taking other medications, patients must inform their doctor or pharmacist, particularly when taking strong CYP3A4 inhibitors, some antibiotics, antifungals, immunosuppressants, and certain heart medications. Elderly patients, those with hypothyroidism, or impaired kidney function are at higher risk for myopathy and should exercise extra caution when taking this medication. This medication can raise blood sugar levels and increase the risk of diabetes, so patients with risk factors for diabetes should regularly monitor their blood sugar levels. Patients taking this medication who experience unexplained muscle pain, weakness, or changes in urine color should notify healthcare professionals immediately, and medication may need to be discontinued if these symptoms occur. This medication should not be administered to patients with certain genetic lactose intolerance, and there is no specific antidote for overdose, so immediate medical attention is necessary in the event of an overdose. Patients taking this medication should inform healthcare professionals of any current medications when being prescribed new ones and must be cautious about drugs that cannot be combined with this medication.

Side effects

Myopathy, rhabdomyolysis, elevated creatine kinase, headache, diarrhea, influenza, upper respiratory tract infection, myalgia, limb pain, fatigue, abdominal pain, viral infection, pharyngitis, sinusitis, arthralgia, low back pain, cough, anaphylaxis, urticaria, rash, angioedema, elevated liver aminotransferase levels, hepatitis, thrombocytopenia, nausea, pancreatitis, dizziness, paresthesia, depression, cholelithiasis, cholecystitis, Stevens-Johnson syndrome, toxic epidermal necrolysis, eosinophilia, systemic symptoms accompanying drug reactions, erythema multiforme, weakness, cataracts, constipation, dyspepsia, flatulence, nausea, eczema, pruritus, rash, muscle cramps, specific cranial nerve dysfunction, oculomotor dysfunction, facial paresis, tremor, peripheral neuropathy, peripheral nerve paralysis, mental disorders, anxiety, sleep disturbances, cognitive impairment, interstitial lung disease, lupus-like syndrome, polymyositis, dermatomyositis, vasculitis, purpura, leukopenia, hemolytic anemia, positive antinuclear antibodies, increased erythrocyte sedimentation rate, arthritis, photosensitivity, fever, chills, flushing, lethargy, dyspnea, cholestatic jaundice, liver fat changes, cirrhosis, fulminant hepatic necrosis, liver cancer, alopecia, various skin changes, lichenoid drug eruption, gynecomastia, decreased libido, sexual dysfunction, ocular muscle paralysis, anemia, elevated aminotransferases, increased ALP, elevated γ-GT, increased bilirubin levels, thyroid dysfunction, increased HbA1c, elevated fasting blood glucose levels, edema, thirst, facial swelling, syncope, insomnia, gastritis, atrophic gastritis, mucous stools, irritable bowel syndrome, sore throat, nocturia, hematuria, increased serum creatine phosphokinase, weight loss

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a tightly sealed container to protect it from air and moisture. To maintain the drug's efficacy, it is advised to store it at room temperature between 1 and 30 degrees Celsius.

Appearance and packaging

Appearance

White to light yellow, bilaterally convex, rectangular tablet

Package unit

30 tablets per box [30 tablets (10 tablets/PTPX3)]

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.